Clinical trial
Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft…
NCT00041392 · Duke University, Other · Completed
Key facts
| NCT number | NCT00041392 |
|---|---|
| Title | Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery |
| Official title | PeriOperative Interventional Neuroprotection Trial (POINT) |
| Acronym | POINT |
| Lead sponsor | Duke University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Disease, Heart Diseases, Cardiovascular Diseases, Neurologic Manifestations |
| Intervention type | Drug |
| Interventions | Magnesium, 0.9% saline |
| Enrollment | 389 |
| Start date | Dec 1, 2001 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Jul 9, 2002 |
| Last update posted | Jul 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: